Detalhe da pesquisa
1.
Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.
Breast Cancer Res
; 22(1): 46, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410705
2.
Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients.
Breast Cancer Res Treat
; 184(1): 123-133, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748297
3.
Patterns in detection of recurrence among patients treated for breast cancer.
Breast Cancer Res Treat
; 184(2): 365-373, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761415
4.
Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG).
Acta Oncol
; 57(1): 31-37, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168427